NCT02814617

The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The investigators performed randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cordyceps sinensis mycelium culture extract (Paecilomyces hepiali, CBG-CS-2) on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-1β, IL-2, IL-4, IL-10, IL-12, IFN-γ, TNF-α).

Conditions

• Immunity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Cordyceps sinensis mycelium culture extract 1.68 g	Cordyceps sinensis mycelium culture extract 1.68 g
DIETARY_SUPPLEMENT	Placebo

Timeline

• Start date: 2015-09-01
• Primary completion: 2015-09-01
• Completion: 2015-11-01
• First posted: 2016-06-28
• Last updated: 2016-06-28

Locations

1 site across 1 country: South Korea